Aleix Prat, Director of Clínic Barcelona Comprehensive Cancer Center (4CB), Professor at the University of Barcelona, Co‑Founder and President of Reveal Genomics, Director of the Breast Cancer Program (IOB‑Pangaea), and Chair of the Advisory Board at Ona Therapeutics., shared posts on LinkedIn:
“Last night in Warsaw, we received accreditation as a Comprehensive Cancer Center from the Organisation of European Cancer Institutes (OECI).
This recognition is the result of many years of work and the dedication of more than 1,000 professionals who make Clínic Barcelona Comprehensive Cancer Center (4CB) possible every day. It belongs to all of them, and to the patients who inspire us to continuously strive for excellence.
I am deeply grateful to everyone who has contributed to this journey. In particular, I would like to thank the members of the 4CB Governing Board and Executive Board, the Clinical Care, Research and Education Boards, and Josep M. Campistol, Susana Puig, Joan Guàrdia Olmos and Antoni Castells Garangou for their leadership and unwavering support.
A very special thank you to Dr. Faust Feu and the entire accreditation team. Their commitment, professionalism, and perseverance were essential to achieving this milestone.
Receiving this recognition in Warsaw was a proud moment, but it is not the destination. It is a new beginning. Our North Star remains Nou Campus Clínic UB Diagonal, where we will continue working to build one of Europe’s leading ecosystems for cancer care, research, innovation, and education.”
Other articles featuring Aleix Prat on OncoDaily.